Asunto(s)
COVID-19 , Melanoma , Control de Enfermedades Transmisibles , Humanos , Melanoma/diagnóstico , Melanoma/epidemiología , Pandemias , SARS-CoV-2Asunto(s)
Antineoplásicos Inmunológicos , Melanoma , Neoplasias Cutáneas , Anticuerpos Monoclonales/uso terapéutico , Antineoplásicos Inmunológicos/uso terapéutico , Humanos , Melanoma/tratamiento farmacológico , Receptor de Muerte Celular Programada 1 , Neoplasias Cutáneas/tratamiento farmacológicoRESUMEN
BACKGROUND: Lipedematous scalp, with or without alopecia, is a poorly known and rarely reported entity. It was first described in 1935 by Cornbleet. It involves increased thickness of the subcutaneous tissue of the scalp, responsible for an overall thickening of the scalp, which may be associated with alopecia, pruritus or painful sensations. Currently, fewer than 50 cases of lipedematous scalp, both with and without alopecia, have been reported in the literature. PATIENTS AND METHODS: Herein we present the case of a 36-year-old woman from the Ivory Coast, who presented scalp pain associated with infiltration of the entire subcutaneous tissue of the scalp seen clinically and confirmed at MRI. Histology added nothing. DISCUSSION: We diagnosed a new case of lipedematous scalp in an African woman. No cause was found. Therapeutic abstention appears the best management strategy.
